We read with great interest the study by Wunsch et al 1 published in this issue of Polish Archives of Internal Medicine, which validated the prognostic ability of 2 previously ide ...
IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their ...
Antibodies to erythrocytes or leukocytes could not be found, but a precipitating antibody reactive with IgA in donor and normal human serum was discovered in the patient's serum. This antibody ...
来自MSN2 个月
Scientists develop new method to isolate 'IgA-coated' gut bacteria that are associated with ...The most abundant type of antibody in our intestine is immunoglobulin A (IgA) which, once released, recognizes, and binds specific gut bacteria. On average, about 35% of the gut bacteria are ...
Saliva-based diagnostics have emerged as a transformative approach in medical testing, offering a non-invasive and efficient alternative to blood sampling. However, the complexity of saliva, which ...
Transcutaneous immunization, a topical vaccine application, combines the advantages of needle-free delivery while targeting the immunologically rich milieu of the skin. In animal studies, this ...
There are five main types (isotypes) of antibodies, each with distinct structures and functions: IgG, IgM, IgA, IgE, and IgD. Illustration of the five major antibody (immunoglobulin) types ...
mouse IgM), and monoclonal antibodies to DX18 (mouse IgM), M18-254 (mouse IgA), DX5 (rat IgM), TX2 (rat IgM), TX1 (rat IgA) as well as human IgM (obtained from a patient with macroglobulinemia ...
Climb Bio Inc. has entered into an exclusive license agreement with Beijing Mabworks Biotech Co. Ltd. for rights to develop and commercialize MIL-116 (now CLYM-116), an anti-APRIL monoclonal antibody ...
Serological testing in people who have IgA deficiency:- What is the sensitivity and specificity of IgG tissue transglutaminase (tTG), IgG endomysial antibodies (EMA) and IgG deamidated gliadin peptide ...
Ipsen and Sutro Biopharma entered a global licensing deal for STRO-003, an ADC targeting ROR1, overexpressed in cancers, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果